Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of Influenza Vaccination (Flu Vac) in Patients Receiving Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NM Allo PBSCT) Compared to Healthy Controls

NCT00419224 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00419224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00419224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of Influenza Vaccination (Flu Vac) in Patients Receiving Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NM Allo PBSCT) Compared to Healthy Controls
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2002
Completion date
April 30, 2003
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza